• Profile
Close

Once-weekly vs every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial

Radiotherapy & Oncology Mar 23, 2018

Quon HC, et al. - Prostate stereotactic body radiotherapy (SBRT) regimens differ in time, dose, and fractionation. The impact of overall treatment time on quality of life (QOL) in patients with prostate cancer was determined herein. Prostate SBRT delivered once per week (QW) vs every other day (EOD) resulted in an improved acute bowel and urinary QOL. Patients should be counselled regarding the potential for reduced short-term toxicity and improved QOL with QW prostate SBRT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay